Hvad er oversættelsen af " BONE MARROW DEPRESSION " på dansk?

• knoglemarvsdepression

Eksempler på brug af Bone marrow depression på Engelsk og deres oversættelser til Dansk

Bone marrow depression is the dose-limiting toxic effect of hydroxycarbamide.
Knoglemarvshæmning er den dosisbegrænsende toksiske effekt af hydroxycarbamid.

In rare cases Remeron can cause disturbances in the production of blood cells bone marrow depression.
I sjældne tilfælde kan Remeron give forstyrrelser i produktionen af blodlegemer knoglemarvsdepression.

Bone marrow depression(granulocytopenia, agranulocytosis, aplastic anemia thrombocytopenia) Eosinophilia.
Hyppighed ikke kendt Knoglemarvsde- pression(granulocytopeni, agranulocytose, aplastisk anæmi trombocytopeni) Eosinofili.

However, possible symptoms of overdose are expected to include nausea, vomiting, diarrhoea and severe bone marrow depression.
Symptomerne på overdosering forventes dog at omfatte kvalme, opkastning, diaré og svær knoglemarvsdepression.

If you have bone marrow depression, blood vessel problems in the brain(including stroke), or severe immune system disease.
Hvis du har knoglemarvsdepression, blodkar problemer i hjernen(herunder apopleksi), eller alvorlig sygdom i immunsystemet.

Suspension or modification of therapy should be considered when drug-induced bone marrow depression is detected see section 4.2.
Afbrydelse eller ændring af behandlingen skal overvejes lægemiddelinduceret knoglemarvsdepression bliver påvist se pkt.

Bone marrow depression Bone marrow depression, usually presenting as granulocytopenia or agranulocytosis, has been reported during treatment with Remeron.
Knoglemarvsdepression Knoglemarvsdepression, der sædvanligvis viser sig som granulocytopeni eller agranulocytose, er blevet rapporteret under behandling med Remeron.

There have been reports of aplastic anaemia and bone marrow depression in patients treated with CellCept, some of which have been fatal.
Der har været indberetninger om aplastisk anæmi og knoglemarvsdepression hos patienter behandlet med CellCept, hvor nogle har været fatale.

The manifestations of acute overdose include nausea, vomiting, diarrhoea, mucositis, gastrointestinal irritation and bleeding, and bone marrow depression.
Symptomerne på akut overdosering omfatter kvalme, opkastning, diarré, mucositis, gastrointestinal irritation og blødning samt knoglemarvssuppression.

Pancytopenia, Bone marrow depression, Anaphylactic shock, Psychotic reactions, Migraine, Olfactory nerve disorders, Hearing impaired, Vasculitis, Pancreatitis, Liver necrosis, Petechiae, Tendon rupture.
Pancytopeni, knoglemarvsdepression, anafylaktisk shock, psykotiske reaktioner, migræne, lugteforstyrrelser, nedsat hørelse, vasculitis, pancreatitis, levernekrose, petekkier, seneruptur.

Patients receiving Myfenax should be instructed to report immediately any evidence of infection, unexpected bruising, bleeding or any other manifestation of bone marrow depression.
Patienter, som får Myfenax, skal have besked om straks at indberette alle tegn på infektion, uventede blodudtrækninger, blødning eller andre manifestationer af knoglemarvsdepression.

Delayed toxicity: Bone marrow depression; alopecia; hemorrhagic cystitis; sterility(may be temporary); pulmonary infiltrates and fibrosis; hyponatremia; leukemia; bladder cancer; inappropriate ADH secretion; cardiac toxicity; amenorrhea.
Forsinket toksicitet: knoglemarvsdepression, alopeci, hæmoragisk cystitis, sterilitet(kan være midlertidig), lungeinfiltrater og fibrose, hyponatriæmi, leukæmi, blærekræft, Upassende ADH-sekretion, kardiotoksicitet, amenoré.

Concurrent use of hydroxycarbamide and other myelosuppressive medicinal products or radiation therapy may increase bone marrow depression, gastro-intestinal disturbances or mucositis.
Samtidig anvendelse af hydroxycarbamid og andre myelosuppressive præparater eller strålebehandling kan forværre en allerede eksisterende myelosuppression(knoglemarvshæmning), gastrointestinale forstyrrelser eller mucositis.

Common symptoms of overdosage are nausea, vomiting, diarrhoea, severe bone marrow depression(including anaemia, thrombocytopenia, leukopenia, and agranulocytosis), acute renal insufficiency as well as irreversible neurologic toxicity(paraparesis/ quadriparesis), Guillan-Barré syndrome, and Brown-Séquard syndrome.
Almindelige symptomer efter overdosering er kvalme, opkastning, diarré, alvolig knoglemarvsdepression(herunder anæmi, trombocytopeni, leukopeni og agranulocytose), akut nyresvigt såvel som irreversibel neurologisk toksicitet(paraparese/ quadriparese), Guillan- Barré- syndrom og Brown- Séquard- syndrom.

Laboratory follow-up including haematological surveillance and lipoproteins determination should also be performed in order to detect early manifestations of copper deficiency, such as anaemia and/ or leukopenia resulting from bone marrow depression, and decrease in HDL cholesterol and HDL/ total cholesterol ratio.
Der bør også foretages laboratorieopfølgning herunder overvågning af hematologi og lidoproteinindhold for at følge tidlige en tidlig manifestation på kobbermangel, som f. eks. anæmi og/ eller leukopeni, der er et resultat af knoglemarvsdepression, og et fald i HDL- kolesterol og HDL/ total kolesterolforholdet.

Neutropenia Caution should be exercised in patients with low leukocyte and/ or neutrophil counts for any reason, in patients receiving medicines known to cause neutropenia, in patients with a history of drug-induced bone marrow depression/ toxicity, in patients with bone marrow depression caused by concomitant illness, radiation therapy or chemotherapy and in patients with hypereosinophilic conditions or with myeloproliferative disease.
Neutropeni Der bør udvises forsigtighed hos patienter med lavt leukocyt- og/ eller neutrofiltal uanset årsag, hos patienter, som får medicin, der er kendt for at medføre neutropeni, hos patienter med tidligere medicin- induceret knoglemarvsdepression/ toksicitet, hos patienter med knoglemarvsdepression forårsaget af samtidig sygdom, strålebehandling eller kemoterapi og hos patienter med hypereosinofile tilstande eller myeloproliferativ sygdom.

Cyklofosfamid(Cytoxan- Bristol-Myers Squibb Oncology; Neosar- Pharmacia)(p.396, Appendix 2; used in chemotherapy) Acute toxicity: Nausea and vomiting; Type 1(anaphylactoid) hypersensitivity; facial burning and metallic taste; visual blurring Delayed toxicity: Bone marrow depression; alopecia; hemorrhagic cystitis; sterility(may be temporary); pulmonary infiltrates and fibrosis; hyponatremia; leukemia; bladder cancer; inappropriate ADH secretion; cardiac toxicity; amenorrhea.
Cyclophosphamid(Cytoxan- Bristol-Myers Squibb Oncology, Neosar- Pharmacia)(S. 396, tillæg 2, Anvendes i kemoterapi) Akut toksicitet: Kvalme og opkastning, type 1(anafylaktisk) overfølsomhed, facial brænding og metallisk smag, sløret syn Forsinket toksicitet: knoglemarvsdepression, alopeci, hæmoragisk cystitis, sterilitet(kan være midlertidig), lungeinfiltrater og fibrose, hyponatriæmi, leukæmi, blærekræft, Upassende ADH-sekretion, kardiotoksicitet, amenoré.

The side effects of cyclophosphamide are mainly depression of bone marrow and bladder problems.
Bivirkningerne til Cyklofosfamid er primært påvirkning af knoglemarv og blæreslimhinden.

Hvordan man bruger "bone marrow depression" i en Engelsk sætning

In some people, this drug may cause bone marrow depression or other types of cancer.

Bone marrow depression from thiotepa has been reported to cause death from bleeding and infection.

When given for a prolonged period, colchicine may cause bone marrow depression and aplastic anemia.

Bone marrow depression is a decreased ability of the bone marrow to produce blood cells.

Discontinuation of the drug should be considered if any evidence of significant bone marrow depression develops.

Carboplatin injection should not be employed in patients with severe bone marrow depression or significant bleeding.

Prolonged or excessive therapeutic doses may result in bone marrow depression which has occasionally been irreversible.

Many adverse events were reported for use of gemcitabine; bone marrow depression is the dose-limiting toxicity.

Bone marrow depression Of all drugs,chloramphenicol is the Buy Vimax Australia most important cause ofaplastic anaemia.

There have been occasional reports of bone marrow depression manifesting as agranulocytosis, leukopenia, thrombocytopenia, and purpura.

Hvordan man bruger "knoglemarvsdepression" i en Dansk sætning

I knoglemarvsdepression easily notice the harder erection and improved libido.

Knoglemarvsdepression ses såvel under behandling og op til 1 år efter behandlingens ophør.

Agranulocytose, Eosinofili, Hæmolytisk anæmi, Knoglemarvsdepression, Leukopeni, Neutropeni, Trombocytopeni.

Check out this article to learn more or contact knoglemarvsdepression system administrator.

Samtidig indgift af allopurinol øger risikoen for knoglemarvsdepression, og der ses nedsat renal clearance af cyclophosphamidmetabolitter.

Ikke almindelige (0,1-1%) Agranulocytose, Aplastisk anæmi, Eosinofili, Hæmolytisk anæmi, Knoglemarvsdepression, Neutropeni, Pancytopeni, Trombocytopeni.

Kontraindikationer for samtidig brug Stoffer, der vides at have betydeligt potentiale for knoglemarvsdepression, må ikke anvendes sammen med Clozapin "Accord" (se pkt. 4.3).

Knoglemarvsdepression kan ses indenfor to uger postoperativt (11) (2a) dog afhængig af det anvendte kemoterapeutikum.

De fleste af disse patienter havde præ-eksisterende hæmatologiske lidelser, der ofte forbindes med knoglemarvsdepression.

I sikkerhedsstudierne og i de kliniske undersøgelser, inklusive langtidsbehandling, blev der ikke observeret tegn på knoglemarvsdepression.